Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indobufen for prevention of deep venous thrombosis in diabetic nephrotic syndrome
ChiCTR1800015065Phase 4Recruiting
- Sponsor
- China-Japan Friendship Hospital Clinical Research Ethics Committee
- Start
- Mar 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Indobufen and clopidogrel in deep vein thrombosis (DVT) (2 arms), sponsored by China-Japan Friendship Hospital Clinical Research Ethics Committee. Primary endpoints: D-dimer, Doppler ultrasound and 1 more. Started Mar 2018; status: recruiting.
02
Drugs
Indobufenclopidogrel
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR1800015065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015065.